Solution structure of the rat P2X4 receptor head domain involved in inhibitory metal binding  by Igawa, Tatsuhiro et al.
FEBS Letters 589 (2015) 680–686journal homepage: www.FEBSLetters .orgSolution structure of the rat P2X4 receptor head domain involved
in inhibitory metal bindinghttp://dx.doi.org/10.1016/j.febslet.2015.01.034
0014-5793/ 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Abbreviations: ECD, extracellular domain of P2X4 receptor; HD, head domain of
P2X4 receptor; HSQC, heteronuclear single quantum coherence; ITC, isothermal
titration calorimetry; MALDI-TOF-MS, matrix-assisted laser desorption/ionization
time-of-ﬂight mass spectroscopy; PDB, Protein Data Bank
⇑ Corresponding author at: Department of Protein Structure, Function and
Design, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1
Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Fax: +81 92 642 6667.
E-mail address: ueda@phar.kyushu-u.ac.jp (T. Ueda).
1 These authors contributed equally to this work.Tatsuhiro Igawa a,1, Yoshito Abe a,1, Makoto Tsuda b, Kazuhide Inoue b, Tadashi Ueda a,⇑
aDepartment of Protein Structure, Function and Design, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
bDepartment of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
a r t i c l e i n f o a b s t r a c tArticle history:
Received 27 November 2014
Revised 22 January 2015
Accepted 23 January 2015
Available online 4 February 2015
Edited by Christian Griesinger
Keywords:
P2X4 receptor
Head domain
Metal binding
NMR
Protein structureThe P2X receptor is an ATP-gated cation channel expressed on the plasma membrane. The head
domain (Gln111–Val167 in the rat P2X4 receptor) regulates ATP-induced cation inﬂux. In this study,
we prepared a head domain with three disulﬁde bonds, such as the intact rat P2X4 receptor con-
tains. NMR analysis showed that the head domain possessed the same fold as in the zebraﬁsh
P2X4 receptor previously determined by crystallography. Furthermore, the inhibitory, divalent,
metal ion binding sites were determined by NMR techniques. These ﬁndings will be useful for the
design of speciﬁc inhibitors for the P2X receptor family.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The P2X4 receptor belongs to the P2X receptor family, which is
an ATP-driven ionic channel expressed on eukaryotic cells [1–3].
When ATP binds to the extracellular domain of the P2X4 receptor,
a conformational change occurs allowing the pores on the trans-
membrane region to open and cations to ﬂow into the cell, causing
activation of the cell [4]. A recent study suggested that P2X4 acti-
vation with ATP on microglial cells induced allodynic neuropathic
pain after damage to peripheral nerves from, for example, surgery,
cancer, diabetes, or infection [5–7]. Therefore, the P2X4 receptor is
a potential drug target against neuropathic pain.
Now that the tertiary and quaternary structures of the P2X4
receptor have been identiﬁed [4,8], it is possible to understand
the function of the P2X4 receptor on the basis of its structure.This structure consists of a functional homo-trimer comprising
three monomeric 40-kDa P2X4 receptors. The monomer has a
dolphin shape and comprises an extracellular head, a body, and
a ﬂuke domain. Each domain interacts with a neighbor subunit
in the homo-trimer. The head domain (Gln111–Val167 in the
rat P2X4 receptor) is a small domain of the P2X4 monomer and
possesses three of the ﬁve disulﬁde bonds in the P2X4 receptor.
The head domain is part of the ATP binding pocket. When ATP
binds to the P2X4 receptor, the head domain and the dorsal ﬁn
region from the neighboring monomer move closer to each other
and stabilize the bound ATP. This movement of the head domain
is then transmitted to the body domain and causes the trans-
membrane pores to open enabling cation inﬂux [4,9]. The head
domain is believed to play a crucial role in ATP-induced cation
inﬂux as removal of 42 residues in the head domain of the
P2X1 receptor leads to insensitivity toward ATP-dependent cation
inﬂux [10].
In this study, we prepared a rat P2X4 head domain expressed by
Escherichia coli. This domain has three disulﬁde bonds. The solution
structure was found to be similar to the head domain of the zebra-
ﬁsh P2X4 receptor previously determined by crystallography. We
also examined the binding sites of copper and zinc divalent metal
ions (Cu2+ and Zn2+), which inhibited and/or potentiated ATP-gated
cation inﬂux [11–15].
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2.1. Preparation of the extracellular domain of the P2X4 receptor in
Escherichia coli
A DNA fragment of the head domain of the rat P2X4 receptor
(rHD; sequence Gln111–Val167, as shown in Fig. 1) with a
His6-tag at the N-terminus was ampliﬁed by PCR. To remove the
N-terminal His6-tag by cyanogen bromide treatment, a methionine
was introduced between the His6-tag and rHD (Fig. 1A). TheA
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Fig. 1. Preparation of rat P2X4 head domain. (A) Primary sequences of the head doma
arrowhead indicates the cyanogen bromide cleavage site. The amino acids with gray and
P2X1 receptors, respectively. Sequences of the head domains in rat P2X1–P2X7 were align
from the SWISS-PROT database. Asterisks indicate the conserved amino acids. (B) SDS–P
(top), rHD reduced by 2-mercaptoethanol at 37 C for 2 h (middle), and rHD after treatm
rHD), 7016.7 (reduced rHD), and 5931.5 (cyanogen bromide-treated HD), respectively. (D
reduced (right) rHD was added to the membrane. (E) CD spectra of the puriﬁed and red
2 mM 2-mercaptoethanol.resultant DNA fragments were ligated into the vector pET-22b(+)
(Novagen, Darmstadt, Germany). The ligated vector was trans-
formed into the E. coli Origami strain (Novagen). The bacteria were
cultured in LB medium or M9minimal medium containing 15NH4Cl
and/or 13C-glucose. Rat HD was overexpressed by induction with
1 mM isopropyl b-D-1-thiogalactopyranoside at 20 C for 20 h.
After overexpression and sonication, the mixture was centrifuged
at 18000g for 40 min. The supernatant was added to an Ni2+-
NTA agarose column (Qiagen, Hilden, Germany), and the column
was eluted in a stepwise manner with 20 mM Tris–HCl bufferins of P2X receptors. The additional His6-tag indicates the rat P2X4 sequence. The
black backgrounds were involved in metal and suramin binding in the rat P2X4 and
ed using ClustalW2 (http://www.clustal.org/clustal2/). All sequences were obtained
AGE of puriﬁed rHD stained with silver. (C) MALDI-TOF-MS spectra of puriﬁed rHD
ent with cyanogen bromide (bottom). The theoretical masses are 7010.7 (puriﬁed
) Dot blotting for reduced and non-reduced rHD. 5 lL (1 mg/ml) of puriﬁed (left) and
uced rHD, analyzed in 20 mM Tris–HCl buffer (pH 8.0). The reduced rHD contained
Table 1
Summary of structural statistics obtained for the head domain of rat P2X4.
Number of distance and dihedral angle constraints
Total NOEs 211
Intraresidue NOEs 67
Sequential NOEs (residues i to i + 1) 82
Medium-range NOEs (residues i to i + 2, 3, 4) 22
Long-range NOEs 40
Hydrogen bond restraints 11  2
Disulﬁde bond restraints 3  3
Dihedral angle restraints (/ + w) 40 + 40
Root mean square deviation (r.m.s.d.) against the mean structure (Å)
rmsd for backbone atoms (residues 115–118, 125–133,
144–166)
0.34 ± 0.11
rmsd for heavy-chain atoms (residues 115–118, 125–133,
144–166)
0.93 ± 0.10
Target function 0.67 ± 0.05
Restraint violations
Average of upper distance (Å) 0.0150 ± 0.0013
Average of maximum upper distance (Å) 0.17 ± 0.03
Average of lower distance (Å) 0.0122 ± 0.0090
Average of maximum lower distance (Å) 0.06 ± 0.05
Average of sum of van der Waals (Å) 2.3 ± 0.1
Average of maximum van der Waals (Å) 0.28 ± 0.01
Average of torsion angle (degree) 0.9813 ± 0.1194
Average of maximum torsion angle (degree) 4.71 ± 0.39
Ramachandran analysis (%)
Residues in the most favored regions 82.6
Residues in the additional allowed regions 17.2
Residues in the generously allowed regions 0.2
Residues in the disallowed regions 0.0
Statistics are derived from a set of the 20 lowest-energy structures. Each structure
was obtained by simulated annealing and derived from a unique starting model.
Ramachandran analysis was performed by PROCHECK [20].
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onto a Super Q Toyopearl column (Tosoh, Tokyo, Japan). The pro-
tein fraction was eluted with a linear gradient from 0 to 0.25 M
NaCl in 100 ml of 20 mM Tris–HCl buffer (pH 8.0). The protein
was conﬁrmed by 15% SDS–PAGE staining silver and MALDI-TOF-
MS. MALDI-TOF-MS was performed using an Autoﬂex III mass
spectrometer (Bruker Daltonics, Bremen, Germany). A typical yield
of the rHD was 10 mg in 1 L LB medium.
2.2. CD spectrometry
The CD spectra were recorded at room temperature with a JAS-
CO J-720W CD spectropolarimeter (Jasco, Tokyo, Japan). Proteins
(10 lM) were dissolved in 20 mM Tris–HCl buffer (pH 8.0).
2.3. Dot blotting
Dot blotting was performed according to a previous paper [16].
In brief, 5 lL (1 mg/ml) of each protein solution was directly added
to the PVDF membrane. Proteins were detected using an anti-rat
P2X4 receptor monoclonal antibody and an alkali-phosphatase-
conjugated goat antimouse IgG (Bio-Rad Laboratories, Hercules,
CA, USA) as a secondary antibody.
2.4. NMR measurements
The NMR spectra were recorded at 25 C on a Varian Unity INO-
VA 600 spectrometer (Varian, Palo Alto, CA, USA). NMR samples
(0.4–0.7 mM 13C and/or 15N double-labeled rHD) were dissolved
in 10 mM acetate buffer (pH 5.0) containing 50 mM urea and 10%
D2O. A series of three-dimensional double- and triple-resonance
experiments (HNCA, HN(CO)CA, HNCBCA, CACBCONH, HNCO,
HN(CA)CO, 15N-edited TOCSY, HCCH-COSY, and HCCH-TOCSY)
were recorded for the assignment of the rHD signals. The NMRPipe
software suite [17] was used to process the data. The resonances of
each residue were assigned using Olivia (fermi.pharm.hokudai.ac.
jp).
2.5. rHD structural calculations
The NOE data from rHD were obtained from 15N- or 13C-edited
NOESY experiments carried out with a mixing time of 150 ms.
CYANA (version 2.1) [18] was used to calculate the structures. A
total of 40 / and w values were estimated using TALOS+ [19].
The distance constraints of the hydrogen and disulﬁde bonds were
incorporated by reference to the crystal structure of zebraﬁsh P2X4
[4,8]. The restraints used for the structure calculations are summa-
rized in Table 1. A total of 200 structures were obtained, and the
mean coordinates were obtained by averaging the coordinates of
the 20 structures with the lowest target function (ﬁnal average tar-
get function = 0.67 ± 0.05). Ramachandran analysis was performed
by PROCHECK [20]. The NMR data and the coordinates used for the
ensemble of NMR structures have been deposited in the BioMa-
gResBank (www.bmrb.wisc.edu) under accession number 11583
and in the PDB under accession code 2rup.
2.6. Removal of the N-terminal His6-tag by cyanogen bromide
treatment
rHD (1 mg) was dissolved in 6 M guanidine-HCl at pH 2
adjusted by HCl and was mixed with 20 mg of cyanogen bromide.
The reaction mixture was gently stirred for 24 h at room tempera-
ture. After the reaction, the cyanogen bromide was removed using
an aspirator. The cyanogen bromide-treated protein was puriﬁed
using a reverse-phase, high-performance liquid chromatography
system using a column (4.6 ID  150 mm, Symmetry300™ C43.5 lm; Waters, Milford, MA, USA). The protein was conﬁrmed
by MALDI-TOF-MS (Fig. 1C). The 1H–15N HSQC spectrum of the
cyanogen bromide treated rHD was shown in Supplementary
Fig. 1.
2.7. Cu2+ and Zn2+ titration
ITC analyses were performed using MicroCal Auto-iTC200 (GE
Healthcare, Little Chalfont, UK). Cu2+ (10 mM) was injected
(1  0.4 lL and 18  2 lL) into 10 lM rHD solution in 50 mM
Tris–HCl (pH 7.5) buffer at 25 C. The data were ﬁtted to a sin-
gle-site binding model using Origin software. We recorded the
two-dimensional 1H–15N HSQC spectra using a 0.1 mM 15N-labeled
and cyanogen bromide-treated rHD in the presence or absence of
various concentrations of Cu2+ or Zn2+, as indicated in the ﬁgure
legends (Figs. 3B and 4A).
3. Results
3.1. Preparation of the head domain of the rat P2X4 receptor
Based on the crystal structure of the zebraﬁsh P2X4 receptor,
we designated the region from Gln111 to Val167 as the head
domain (Fig. 1A). We then overexpressed the head domain of the
rat P2X4 receptor (rHD) in the Origami strain. The silver-stained
SDS–PAGE of the expressed and puriﬁed rHD is shown in Fig. 1B.
The HD of the zebraﬁsh P2X4 receptor has six cysteines that
form three disulﬁde bonds, as determined from the crystallo-
graphic structure [4,8]. We examined whether these disulﬁde
bonds were retained in the rHD. The MALDI-TOF spectra of the
puriﬁed rHD and of the rHD reduced by 2-mercaptoethanol are
shown in Fig. 1C. Although the mass of the reduced rHD was
7014, the peak of the puriﬁed rHD was 7009, indicating that the
AB C D
Fig. 2. NMR spectrum and structure of rat P2X4 head domain. (A) 1H–15N HSQC spectra of 0.4 mM rHD with His6-tag. The measurements were performed in 10 mM acetate
buffer (pH 5.0) containing 50 mM urea and 10% D2O at 25 C. Backbone NH and tryptophan NE1 resonances are labeled with their single-letter codes and residue numbers.
The box indicates the major and minor peaks of Glu154 (see text). (B) Superposition of 20 simulated annealing models of rHD (residues 111–167; PDB code, 2rup). (C) Three
disulﬁde bonds (Cys116–Cys165, Cys126–Cys149, and Cys132–Cys159) are represented in the rHD structure. (D) Superposition of the head domain of the zebraﬁsh P2X4
receptor determined by X-ray crystallography (PDB code: 4DW0; red) and that of the rat P2X4 receptor determined by NMR (blue). Superposition was performed using
PyMOL (www.pymol.org). The root mean square deviation is 1.75 Å.
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presence of disulﬁde bonds using a monoclonal antibody that we
have previously prepared [16]. This antibody is sensitive to disul-
ﬁde bond formation in the head domain. The results of dot blotting
revealed that this monoclonal antibody reacted with the puriﬁed
rHD, but not with the reduced rHD (Fig. 1D), indicating that disul-
ﬁde bonds formed in the puriﬁed rHD. In contrast, the CD spectrum
of both the puriﬁed and reduced rHD showed a random coil struc-
ture (Fig. 1E).
3.2. Solution structure of the head domain
NMR analysis was conducted to conﬁrm whether the rHD has a
folded structure. The 1H–15N HSQC spectrum of rHD (Fig. 2A) con-
sisted of dispersed and separated peaks, suggesting that rHD pos-
sesses a folded structure. We assigned the 1H, 15N, and 13C
chemical shifts of the main chain of rHD. These assignments
revealed major and minor peaks in the main-chain 1H–15N peaks
of the residues from Val146 to Thr158 and in the side chain of
Trp164. The major and minor peaks of Glu154, for example, are
shown in the box in Fig. 2A. The minor peaks gradually disap-
peared as the temperature decreased (Supplementary Fig. 2A),
indicating that a chemically minor conformation existed in this
region (Supplementary Fig. 2B). Using the chemical shift assign-
ments of a major conformation, we obtained several restraintsfor structural calculation, as shown in Table 1. A total of 200 struc-
tures were calculated, and the 20 lowest-energy structures were
selected. The ﬁnal 20 structures were superimposed on the mean
coordinate positions for the backbone atoms (N, Ca, C0) of residues
115–118, 125–133, and 144–166 of the rHD (Fig. 2B). The root
mean square deviation (r.m.s.d.) from the mean coordinate posi-
tion was 0.34 ± 0.11 Å for the well-deﬁned backbone atoms of
the residues. The formation of three disulﬁde bonds in rHD
(Cys116–Cys165, Cys126–Cys149, and Cys-132–Cys159) was rea-
sonable for the calculated structure based on the other distance
constraints (Fig. 2C). The structure of the fold in the determined
rHD was quite similar to the head domain of the zebraﬁsh P2X4
receptor. The two head domains could be superimposed on each
other with low r.m.s.d. (1.72 Å), as shown in Fig. 2D.
3.3. Divalent metal ion binding to rHD
In previous studies, the head domain was determined as a
potential binding site for the divalent metal ions, Zn2+ and Cu2+,
from site-directed mutagenesis experiments [12–14]. We ﬁrst
tried to conﬁrm whether Cu2+ ions bound to rHD, with a deletion
His6-tag using ITC. We observed an exothermic reaction during
the titration of the Cu2+ ion (Fig. 3A). Calorimetric parameters sug-
gested that the dissociation constant of the complex between the
Cu2+ ion and rHD was 600 lM.
A B
C
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Fig. 3. Cu2+ binding site in rHD. (A) ITC analysis of 10 lM rHD binding to 10 mM Cu2+ in 50 mM Tris–HCl (pH 7.5) buffer at 25 C. Estimated Kd value is approximately
600 lM. (B) A part of the 2D 1H–15N HSQC spectra of cyanogen bromide-treated rHD (0.1 mM) in the absence (left) and presence (right) of 0.5 mM Cu2+ at 25 C. The circles
indicate the peaks that disappeared with the addition of Cu2+. (C) The ratios of the peak intensities in the presence and absence of 0.5 mM Cu2+ ion shown for the backbone
amides as a function of sequence number. (D) Mapping of the Cu2+ binding site on the rHD. The residues that have largely decreased signal intensity upon Cu2+ ion binding are
shown in orange and the head domains are shown in light blue. The Cu2+ binding site is mapped on the rHD structure. Stick models show the residues involved in Cu2+
binding. The yellow circle shows the putative bound Cu2+ ion. The orientation is the same as in the structures in Fig. 2 (B–D). (E) The Cu2+ binding site mapped on the overall
structural models of the ATP unbound (left) and bound (right) rat P2X4 receptor. Homology modeling was conducted using Molecular Operating Environment (MOE) 2008.09
molecular modeling software (Chemical Computing Group, Montreal, Canada) based on the crystal structure of the zebraﬁsh P2X4 receptor (PDB code: 4DW0, 4DW1).
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using NMR analysis. In the presence of 0.5 mM Cu2+, several
1H–15N cross peaks disappeared (Fig. 3B). Because the Cu2+ ion is
paramagnetic, its proximity to the NMR spins causes the NMR sig-
nal to broaden. Therefore, disappearance of cross peaks indicates
that these residues are close to the Cu2+ ion. Fig. 3C shows the
ratios of the signal intensities of the HSQC 1H–15N cross peaks in
the presence and absence of 0.5 mM Cu2+. These results indicate
that the peak intensities of Thr117–Ile125, Val137–Ala145,
Cys159, Val161, and Ala162 are strongly decreased in the presence
of Cu2+. These residues are mapped on the determined rHD struc-
ture (Fig. 3D). Because the residues affected by the Cu2+ ion were
localized in one region, we postulated that this region is a metal
binding site.
As the Zn2+ ion concentration was increased to 10 mM, some
1H–15N cross peaks were slightly shifted (Fig. 4A). Therefore, theZn2+ ion also affected the conformation of the rHD. The dissociation
constants calculated from the chemical shift changes in the titra-
tion of Zn2+ ions were more than 1 mM, which is weaker than those
in the titration of Cu2+ ions. The chemical shift change of each res-
idue revealed that the binding sites of these two ions are similar
(Fig. 4B).
4. Discussion
Based on the crystal structure of the P2X4 receptor in ATP
bound and unbound states, it has been reported that the HD func-
tions as an independent domain during the open and closed con-
formations of the receptor [4]. In this study, we prepared rHD as
a separate domain closely located to the ATP binding site. Together,
the CD, MALDI-TOF MS, and NMR spectra and the reactivity against
a monoclonal antibody (Figs. 1 and 2) suggest that the expressed
AB
Fig. 4. Zn2+ binding to rHD. (A) A part of the 2D 1H–15N HSQC spectra of cyanogen
bromide-treated rHD (0.1 mM) in the absence (black) and the presence of 2 mM
(magenta), 5 mM (orange), and 10 mM (red) Zn2+ at 15 C. (B) Chemical shift
changes in the presence and the absence of 10 mM Zn2+ ions shown for the
backbone amides as a function of sequence number of rHD.
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same as the intact P2X4 receptor (Fig. 2C). The disulﬁde bonds play
an important role in the folding of the rHD structure, as deter-
mined from the reduction of the disulﬁde bond (Fig. 1D). The dele-
tion of disulﬁde bonds in the head domain leads to impairment of
ATP-dependent P2X4 receptor function [10,21]. Therefore, the
three disulﬁde bonds are used for the maintenance of head domain
structure and function.
As NMR analysis determined that the folding in the rHD struc-
ture is similar to that of the head domain of the zebraﬁsh P2X4
receptor (Fig. 2D), it is likely that the head domain structure is con-
served in P2X4 receptor homologs. In the crystal structure of zeb-
raﬁsh P2X4 receptor, the head domain structures in the ATP bound
and unbound states were very similar [4]. However, in the head
domain, particularly in the b-turn structure from Thr146 to
Thr158, the B-factor values of the Ca atoms decreased in the ATP
bound state, but not in the unbound state in zebraﬁsh P2X4 (Sup-
plementary Fig. 2C), suggesting that ATP binding suppressed the
head domain’s mobility. Our NMR spectrum of rHD in solution sug-
gests that this b-turn structure has at least two conformations,
constrained at low temperatures (Supplementary Fig. 2A). Proba-
bly, this ﬁnding is consistent with the result that ATP binding con-
strains a variety of the conformations of the head domain in
zebraﬁsh P2X4.
Metal ions affect the ATP-dependent activation of the P2X fam-
ily receptor. In the rat P2X2 receptor, ATP-dependent activity is
potentiated by Zn2+ ions because the Zn2+ ion, chelated by two
His residues in the head and dorsal ﬁn domains, ﬁxes the ATP-
bound channel in the open position [22,23]. Divalent copper and
zinc metal ions also inﬂuence P2X4 activity. To elucidate the effectof these metal ions on the P2X4 receptor, several site-directed
mutagenesis studies have been carried out [12–14]. These studies
suggest that His140 and Asp138 in the head domain are key resi-
dues involved in metal ion binding. The metal binding site identi-
ﬁed in rHD contained His140 and Asp138, as well as the acidic
residues, Glu118 and Asp121 (Fig. 3D). These residues are likely
to be deeply involved in metal binding in the head domain. These
residues are not conserved in P2X1–7 (see Fig. 1A for a comparison
of primary sequences). This observation is supported by previous
results that the effects of divalent metal ions are different among
the P2X families [15,22–26].
ATP-dependent cation inﬂux in the rat P2X4 receptor is sup-
pressed by Cu2+ ions or by a high concentration of Zn2+ ions [11].
This ﬁnding is consistent with the NMR and ITC results for rHD,
in which the Cu2+ ion was found to bind to rHD more tightly than
the Zn2+ ion. In D138A and H140A mutants, in which the metal
binding site is disrupted, the inhibitory effect of Cu2+ and Zn2+ ions
is removed [12,14]. However, the ATP-dependent cation inﬂux in
the rat P2X4 receptor is facilitated by a low concentration of Zn2+
ions [11,27]. Additionally, cation inﬂux in the D138A and H140A
mutants is potentiated by Zn2+ ions in a concentration-dependent
manner [12–14]. Considering these results, it is expected that there
is another Zn2+ binding site for potentiation in the rat P2X4 extra-
cellular domain. For example, Coddou et al. suggested that Cys132
in the head domain might be another potentiation site [14]. How-
ever, in the preset study, we were unable to ﬁnd a notable chemical
shift perturbation around Cys132 in the presence of zinc ions in
rHD.
Suramin and its derivative NF449 are speciﬁc inhibitors of the
human P2X1 receptor. Positively charged residues (Lys136–
Lys140, corresponding to Ser136–His140 in the rat P2X4 receptor,
as indicated in Fig. 1A) in the head domain contribute to the spec-
iﬁcity of the P2X1 receptor to suramin and NF449 [10,28]. The
P2X1 inhibitor binding site is in a similar position to the inhibitory
metal binding site identiﬁed in rHD. In P2X4 receptor structures,
the surface of the metal or inhibitor binding site interacted with
the body domain in the ATP bound form but not in the ATP free
form (Fig. 3E) [4]. Therefore, the binding of an inhibitory metal
ion or suramin could disrupt the formation of the ATP bound form,
resulting in inhibition of the cation inﬂux. Alternatively, as
Ala118–Ile125 (corresponding to Pro117–I125 in the rat P2X4
receptor) is a potential ATP binding site [29], these inhibitory mol-
ecules directly bind to the ATP binding site, resulting in inhibition
of ATP binding. Therefore, the head domain, particularly the metal
binding site, is a potential target for the inhibition of P2X receptors.
The sequence of the metal binding site has low similarity among
P2X1–7 receptors, and the interspeciﬁc sequence similarity is also
low (Fig. 1A). These results suggest that the metal binding site is a
potential site for a speciﬁc inhibitor against each of the P2X family
of molecules.
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